Jinxin Fertility Group (OTCMKTS:JXFGF – Get Free Report) is expected to release its results before the market opens on Thursday, March 26th. Analysts expect the company to announce earnings of $0.0043 per share and revenue of $190.1590 million for the quarter.
Jinxin Fertility Group Price Performance
JXFGF stock opened at $0.29 on Thursday. Jinxin Fertility Group has a 52-week low of $0.28 and a 52-week high of $0.49. The company’s 50-day simple moving average is $0.29 and its 200-day simple moving average is $0.29.
Wall Street Analyst Weigh In
Separately, The Goldman Sachs Group cut Jinxin Fertility Group to a “sell” rating in a report on Thursday, February 5th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Sell”.
Jinxin Fertility Group Company Profile
Jinxin Fertility Group (OTCMKTS:JXFGF) is a Cayman Islands–incorporated company that provides a full spectrum of assisted reproductive and fertility services through its network of clinics and laboratory facilities in mainland China. The company offers in vitro fertilization (IVF), intrauterine insemination (IUI), egg and sperm cryopreservation, pre-implantation genetic testing and counseling, and related reproductive health services designed to support couples and individuals seeking to build families.
Since its founding in 2014, Jinxin Fertility Group has expanded its presence into multiple major cities, partnering with local hospitals and healthcare institutions to deliver standardized clinical protocols and advanced laboratory capabilities.
Featured Stories
Receive News & Ratings for Jinxin Fertility Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jinxin Fertility Group and related companies with MarketBeat.com's FREE daily email newsletter.
